Gapping up
In reaction to earnings/guidance:
- MDB +25.6%, THO +4.8%, GWRE +4.4%, CPB +2.3%
Other news:
- RXDX +191.2% (Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies)
- REPL +37.6% (enters into clinical collaboration agreement with Roche (RHHBY) for the development of RP3 in colorectal cancer and hepatocellular carcinoma)
- IVVD +3.1% (appoints new COO)
- AXON +0.9% (prices offering of $600 mln of 0.50% Convertible Senior Notes due 2027)